SECsense Logo

Dexcom, Inc. 8-K Report: Key Updates from May 9, 2025

$DXCM
Form 8-K
Filed on: 2025-05-13
Source
Dexcom, Inc. 8-K Report: Key Updates from May 9, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Dexcom, Inc.
  • Headquarters Address: 6340 Sequence Drive, San Diego, CA 92121
  • Phone Number: 858-200-0200
  • SEC CIK Number: 0001093557
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001093557
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: May 9, 2025
  • Period Covered: The report covers the same date, May 9, 2025.
  1. Stock Information:
  • Common Stock Par Value: $0.001 per share
  • Stock Symbol: DXCM
  • Exchange: NASDAQ
  1. Filing Reference:
  • Schema Reference: dxcm-20250509.xsd

Insights:

  • Current Report: The filing is categorized as an 8-K report, which typically indicates that significant events or changes have occurred that shareholders should be made aware of. Analyzing the details of this filing could provide insights into recent developments within Dexcom, Inc.
  • Stock Performance: The mention of stock information is crucial for investors. The par value indicates the minimum price at which shares can be issued, while being listed on NASDAQ under the symbol DXCM allows for public trading and investor participation.
  • Location: Being based in San Diego, CA, aligns the company within a tech and biotech hub, which can be advantageous for its operations and partnerships.

Overall, this report is a snapshot of a specific date and may contain critical information regarding corporate events or financial performance that could influence investor decisions. Further analysis of the complete 8-K filing would be required to assess the specifics of the reported events or changes.